Serpin Pharma, LLC

Calculating rank

USPTO Granted Patents = 7

EPO Patents = 4

Forward Citations = 11

Loading Chart...

3 inventors (with patents filed for the assignee):

Cohava Gelber (7 out of 10 patents)

Soren Mogelsvang (5 out of 5 patents)

Dana Austin (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12291581 - Serpin peptides and methods of using the same (2025-05-06),

2. 11779630 - Peptides and methods of using the same (2023-10-10),

3. 11020462 - Methods for treatment of diseases (2021-06-01),

4. 10899797 - Peptides and methods of using same (2021-01-26),

5. 10214562 - Peptides and methods of using same (2019-02-26),

6. 9951104 - Peptides and methods of using same (2018-04-24),

7. 8975224 - Peptides and methods of using same (2015-03-10),

Company Overview

Serpin Pharma, LLC is a cutting-edge pharmaceutical company specializing in the development and commercialization of novel therapeutics for rare and chronic diseases. Our mission is to improve the lives of patients worldwide through innovative research and advanced drug delivery technologies. With a dedicated team of scientists and industry experts, we strive to bring groundbreaking treatments to market quickly and efficiently.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

7 Patents

#8 in Manassas, VA

#709 in Virginia

#39,947 in US

Manassas, VA, United States of America

Serpin Pharma, LLC

Forward Citations = 11

3 inventors:

Cohava Gelber (7 out of 10 patents)

Soren Mogelsvang (5 out of 5 patents)

Dana Austin (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Serpin Pharma, LLC. Retrieved from https://idiyas.com/company/serpin-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]